Concepedia

Yuanke Li

YL

Statistics

Publications

6

Citations

238

H-Index

6

Active since

2014

Affiliations

Nankai University(Current)

China Pharmaceutical University

State Key Laboratory of Medicinal Chemical Biology

Yuanke Li is an author at Nankai University specializing in nanomedicine, nanoparticle drug delivery, and oncology.

ORCID

Publications per year

2014–2023

6

Publications

6

CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model

Ruikun Wang, Jingru Chen, Wei Wang et al. · Journal for ImmunoTherapy of Cancer · 2022 · 54 citations · Full text

, , +17

Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy

Yuanke Li, Yuanyuan Wu, Leaf Huang et al. · Journal of Controlled Release · 2016 · 50 citations

, , +16

Tumor Cell Nanovaccines Based on Genetically Engineered Antibody‐Anchored Membrane

Yuanke Li, Haoqi Zhang, Haoqi Zhang et al. · Advanced Materials · 2023 · 46 citations · Full text

, , +17

Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles

Ting Zhang, Hui Xiong, Fatima Zohra Dahmani et al. · Nanotechnology · 2015 · 37 citations

, , +17

Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid

Jing Yao, Yuanke Li, Xiaojing Sun et al. · International Journal of Nanomedicine · 2014 · 28 citations · Full text

, , +17

1–5 of 6